Published Date: 2-Nov-2021
Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
According to a new report Global Refractive Surgery Devices Market, published by KBV research, The Global Refractive Surgery Devices Market size is expected to reach $331.5 Million by 2027, rising at a market growth of 9.4% CAGR during the forecast period.
The Astigmatism segment would exhibit the fastest growth rate in the refractive surgery devices market over the forecast years. This segment would fuel the market as there is a rise in the number of cases of astigmatism disorder and improvements in technology. Based on the report by American Optometric Association, approximately everybody is suffering from astigmatism and can be treated with the help of refractive surgery. These aspects are projected to augment the growth of the segment over the forecast period.
The hospitals segment acquired the greatest revenue share in 2020. Ophthalmic refractive surgical devices find their excessive application in hospitals as they offer durable shelf life, thereby anticipated to drive the growth of the segment. In addition, some factors such as enhanced healthcare facilities, favorable reimbursement policies, and a growing number of refractive surgeries are estimated to fuel the hospital segment growth during the forecast years.
North America acquired the highest revenue share of the refractive surgery devices market in 2020. Factors such as the existence of major market players, the accessibility of effective reimbursement policies, and the high incidence of refractive errors are anticipated to drive the growth of the regional market.
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Carl Zeiss Meditec AG, Topcon Corporation, Novartis AG, Glaukos Corporation, Johnson & Johnson, Essilorluxottica SA, Bausch Health Companies, Inc., SCHWIND Eye-Tech-Solutions GmbH, NIDEK CO., LTD., and Quantel Medical (Lumibird Group).
By End Use
Unique Offerings from KBV Research